conferencepenny

145 results found.

Top Stocks matching your search for "conference penny"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
HTGM

HTG Molecular Diagnostics Inc

-37.26%

$4.67 - $2.93

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Dec, 29, 2022

$HTGM I like how she naps instead of bleeds $7.5... See more

Dec, 13, 2022

$HTGM great news webcast went well bullish

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 6, 2023

Freshly approved drug and undervalued would mean t... See more

Dec, 29, 2022

Amazing positive news from the TGTX 20221229 confe... See more

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
VLON

Vallon Pharmaceuticals Inc

49.05%

$0.28 - $0.41

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

No reviews available.

HTGM

HTG Molecular Diagnostics Inc

-37.26%

$4.67 - $2.93

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Dec, 29, 2022

$HTGM I like how she naps instead of bleeds $7.5 offering closed, $15 PT released, tiny float, 800% ctb, EOY PR, and January London conference.

Dec, 13, 2022

$HTGM great news webcast went well bullish

Dec, 13, 2022

$HTGM after conference this could fly!

Dec, 13, 2022

$HTGM slap πŸ‘‹ the ask, load and lock πŸ”’ and enjoy the ride, don’t forget 11 est conference time

TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 6, 2023

Freshly approved drug and undervalued would mean the JP conference should be ideal for us.

Dec, 29, 2022

Amazing positive news from the TGTX 20221229 conference call, FDA approved, 🚨πŸ”₯🚨 Ublituximab Briumvi: 1) No need for additional funds, no offering, no need for capital raise, because 220 million in cash reserves expected to last until mid 2024.

VLON

Vallon Pharmaceuticals Inc

49.05%

$0.28 - $0.41

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

No reviews available.